VAERS reports by lot

GSK Varicella/Shingles lot T2CS3: VAERS reports

28 VAERS reports list lot T2CS3 as a GSK Varicella/Shingles vaccine, received between 2020-01-18 and 2021-02-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3032%
Injection-site / Local reaction1718%
Dermatological (non-injection-site)1314%
Neurological1011%
Musculoskeletal910%
Allergic / Anaphylactic44%
Gastrointestinal44%
Psychiatric / Neuropsychiatric44%
Cardiac / Cardiovascular22%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida3
Pennsylvania3
Arizona3
Oregon2
New York2
Michigan2
California2
Kansas1
Tennessee1
Minnesota1
Washington1
Oklahoma1

Reports by month received

2020-012
2020-027
2020-033
2020-051
2020-062
2020-072
2020-083
2020-092
2020-101
2020-121
2021-012
2021-022

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.